Next Article in Journal
Photoinduced Glycerol Oxidation over Plasmonic Au and AuM (M = Pt, Pd and Bi) Nanoparticle-Decorated TiO2 Photocatalysts
Next Article in Special Issue
Mechanical and Physicochemical Properties of Newly Formed ZnO-PMMA Nanocomposites for Denture Bases
Previous Article in Journal
Non-Canonical Activation of the Epidermal Growth Factor Receptor by Carbon Nanoparticles
Review

ZnO Nanostructures for Drug Delivery and Theranostic Applications

1
School of Chemistry and CRANN, Trinity College, The University of Dublin, Dublin 2, Ireland
2
Department Chemistry in Pharmaceutical Sciences, School of Pharmacy , Universidad Complutense de Madrid, Instituto de Investigación Sanitaria Hospital 12 de Octubre i+12, 28040 Madrid, Spain
3
Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Avenida Monforte de Lemos, 3-5, 28029 Madrid, Spain
*
Author to whom correspondence should be addressed.
Nanomaterials 2018, 8(4), 268; https://doi.org/10.3390/nano8040268
Received: 13 March 2018 / Revised: 17 April 2018 / Accepted: 18 April 2018 / Published: 23 April 2018
In the last two decades, zinc oxide (ZnO) semiconductor Quantum dots (QDs) have been shown to have fantastic luminescent properties, which together with their low-cost, low-toxicity and biocompatibility have turned these nanomaterials into one of the main candidates for bio-imaging. The discovery of other desirable traits such as their ability to produce destructive reactive oxygen species (ROS), high catalytic efficiency, strong adsorption capability and high isoelectric point, also make them promising nanomaterials for therapeutic and diagnostic functions. Herein, we review the recent progress on the use of ZnO based nanoplatforms in drug delivery and theranostic in several diseases such as bacterial infection and cancer. View Full-Text
Keywords: ZnO nanoparticles; Quantum dots; theranostic; drug delivery; anti-tumour; diabetes treatment; anti-inflammation; antibacterial; antifungal; wound healing ZnO nanoparticles; Quantum dots; theranostic; drug delivery; anti-tumour; diabetes treatment; anti-inflammation; antibacterial; antifungal; wound healing
Show Figures

Graphical abstract

MDPI and ACS Style

Martínez-Carmona, M.; Gun’ko, Y.; Vallet-Regí, M. ZnO Nanostructures for Drug Delivery and Theranostic Applications. Nanomaterials 2018, 8, 268. https://doi.org/10.3390/nano8040268

AMA Style

Martínez-Carmona M, Gun’ko Y, Vallet-Regí M. ZnO Nanostructures for Drug Delivery and Theranostic Applications. Nanomaterials. 2018; 8(4):268. https://doi.org/10.3390/nano8040268

Chicago/Turabian Style

Martínez-Carmona, Marina, Yurii Gun’ko, and María Vallet-Regí. 2018. "ZnO Nanostructures for Drug Delivery and Theranostic Applications" Nanomaterials 8, no. 4: 268. https://doi.org/10.3390/nano8040268

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop